Related Experiment Video
Updated: Jun 13, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Proteomics-based biomarkers in chronic obstructive pulmonary disease.
Hong Chen1, Diane Wang, Chunxue Bai
1Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Journal of Proteome Research
|April 15, 2010
Summary
This review discusses using proteomic analysis to find new biomarkers for chronic obstructive pulmonary disease (COPD). Standardizing COPD proteomic studies is crucial for accurate diagnosis and treatment monitoring.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Proteomics
Background:
- Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterized by airflow obstruction.
- Proteomic analysis offers potential for identifying novel biomarkers for COPD diagnosis, prognosis, and therapy.
- Various human biological samples (lung tissue, lavage, sputum, serum) are utilized in COPD proteomics research, each with advantages and limitations.
Purpose of the Study:
- To review the feasibility of clinical proteomic studies in COPD.
- To identify potential COPD biomarker candidates in human samples.
- To discuss the criteria for disease specificity, sensitivity to progression, and association with patient status.
Main Methods:
- Review of existing literature on COPD proteomics.
- Discussion of sample types and their suitability for proteomic analysis.
- Analysis of criteria for biomarker validation in COPD.
Main Results:
- Proteomic analysis can identify sensitive and specific biomarkers for COPD.
- Challenges include standardizing study design, sample handling, and data analysis.
- Biomarker candidates must correlate with disease severity, progression, and therapeutic response.
Conclusions:
- Standardized clinical proteomic studies are essential for advancing COPD research.
- Validated biomarkers are needed for accurate diagnosis, prognosis, and monitoring of COPD.
- Further research should focus on establishing clear criteria for subject selection, data analysis, and biomarker validation.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.